All Stories

  1. Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention
  2. Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin‐strut drug‐eluting coronary stents in the ULTRA registry
  3. Impact of the ISCHEMIA trial on the role of noninvasive diagnostic pathways in patients with chronic coronary syndrome
  4. Pharmacology and Clinical Development of Factor XI Inhibitors
  5. Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
  6. Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective
  7. Dual antiplatelet therapy in patients at high bleeding risk: less is more—more or less
  8. Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial
  9. Antithrombotic therapy after transcatheter aortic valve implantation
  10. Reply
  11. Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes
  12. 615 Characterization of actionable bleeding and thrombotic trade-offs in patients undergoing percutaneous coronary intervention
  13. 806 Scout post-PCI instantaneous wave-free ratio as a driver of functional complete
  14. 807 Wellens syndrome: a rare entity not to underestimate
  15. Efficacy and Safety of Aspirin for Primary Cardiovascular Risk Prevention in Younger and Older Age: An Updated Systematic Review and Meta-analysis of 173,810 Subjects from 21 Randomized Studies
  16. Differences in coronary artery disease and outcomes of percutaneous coronary intervention with drug-eluting stents in women and men
  17. Determinants of Popularity and Natural History of Social Media Accounts in Interventional Cardiology
  18. Remote monitoring for heart failure management during COVID-19 pandemic
  19. Cerebrovascular disease—what is the role of dual antiplatelet therapy for the prevention and treatment of ischemic stroke?
  20. Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
  21. Outcomes of renin–angiotensin–aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis
  22. Unmasking psychological reasons of delay in acute coronary syndromes presentation during the COVID‐19 pandemic
  23. Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
  24. Long-term monotherapy with ticagrelor after coronary stenting: the GLOBAL LEADERS study
  25. Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndrome
  26. Stroke After Transcatheter Aortic Valve Replacement
  27. Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update
  28. The Conundrum Surrounding Racial Differences on Ischaemic and Bleeding Risk with Dual Anti-Platelet Therapy
  29. Platelet Function Testing after Transcatheter Aortic Valve Implantation
  30. Risk Stratification for Bleeding in the Elderly with Acute Coronary Syndrome: Not So Simple